Alembic, Aurobindo Recall Drugs In US Market freepressjournal.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from freepressjournal.in Daily Mail and Mail on Sunday newspapers.
Alembic Pharmaceuticals and Aurobindo Pharma are recalling products in the US due to manufacturing problems. Alembic is recalling 82,400 bottles of Tobramycin Ophthalmic Solution due to “Failed Impurities/Degradation Specifications.” Meanwhile, Aurobindo Pharma is recalling 48 bottles of Rufinamide Tablets, in both 200 mg and 400 mg doses, due to cGMP (current good manufacturing practice) deviations, USFDA said. The batch was released prior to approval. Rufinamide tablets are used to treat seizure disorders.
New Jersey-based Sun Pharmaceutical Industries Inc is recalling 7,313 bottles of Methylphenidate Hydrochloride tablets due to the "presence of foreign substance: metal embedded in a tablet", the USFDA stated.
Get latest articles and stories on Latest News at LatestLY. Domestic drug makers Sun Pharma and Alembic are recalling products in the US market due to manufacturing issues, according to the US Food and Drug Administration (USFDA). Latest News | Sun Pharma, Alembic Recall Drugs in US Market.